|Stacey McCann, Ph.D.
|Michael D. Reynolds, M.B.A.
ONCrg employs highly skilled consultants with a deep understanding of clinical medicine and the complex mechanisms underlying cancer pathogenesis. Through rigorous and sophisticated methodologies, our firm interprets numerous scientific, clinical, and therapy area developments on an ongoing basis and is adept at evaluating the commercial impact of complicated interconnected market events and how changes in treatment trends, patient populations, and risk factors will weigh into the future marketplace.
We are committed to helping our clients succeed in creating winning strategies and making the right business decisions for their new products, brands, franchises, partnerships, and alliances. By empowering talented consultants that intensely focus on oncology drug markets, and working hand-in-hand with clients to develop the most relevant forward-looking resources possible, we achieve new standards of analytical excellence and deliver the most accurate, insightful, and robust market planning resources available anywhere in this challenging and pivotal healthcare arena.